RhinoCare

Company Overview

Snapshot

Founded in December 2014 by Dan Shaham, RhinoCare operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on the design, development, and prototype production of its next-generation RhinoTherm device, an inhaler utilizing hyperthermia technology from the Weizmann Institute of Science for nasal congestion relief.

Business overview

RhinoCare is a medical device company specializing in respiratory solutions within the Health Tech & Life Sciences sector. The company's core product is the RhinoTherm, an inhaler device designed to alleviate nasal congestion symptoms through hyperthermia technology. RhinoCare targets the healthcare market, specifically patients, with a business model that includes B2B2C distribution.

Company Intelligence Q&A

What is RhinoCare's primary product?

RhinoCare's primary product is the RhinoTherm, an inhaler device that uses hyperthermia technology to provide relief from nasal congestion symptoms.

When was RhinoCare founded?

RhinoCare was founded in December 2014.

Who is the founder of RhinoCare?

Dan Shaham is the founder of RhinoCare.

What stage of funding is RhinoCare currently in?

RhinoCare is currently in the Pre-Funding stage, indicating it is seeking initial investment to support its development and growth.

What technology does RhinoCare utilize in its device?

RhinoCare utilizes hyperthermia technology from the Weizmann Institute of Science in its RhinoTherm inhaler device.